1. Home
  2. GKOS vs ORN Comparison

GKOS vs ORN Comparison

Compare GKOS & ORN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$113.41

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Logo Orion Group Holdings Inc.

ORN

Orion Group Holdings Inc.

HOLD

Current Price

$10.44

Market Cap

409.8M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
ORN
Founded
1998
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Military/Government/Technical
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
409.8M
IPO Year
2015
2007

Fundamental Metrics

Financial Performance
Metric
GKOS
ORN
Price
$113.41
$10.44
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
2
Target Price
$123.62
$11.25
AVG Volume (30 Days)
877.3K
258.3K
Earning Date
10-29-2025
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.24
Revenue
$469,820,000.00
$835,917,000.00
Revenue This Year
$31.15
$6.40
Revenue Next Year
$24.15
$3.28
P/E Ratio
N/A
$43.19
Revenue Growth
30.38
7.02
52 Week Low
$73.16
$4.64
52 Week High
$163.71
$11.90

Technical Indicators

Market Signals
Indicator
GKOS
ORN
Relative Strength Index (RSI) 73.39 53.46
Support Level $105.88 $10.19
Resistance Level $110.87 $11.90
Average True Range (ATR) 3.17 0.54
MACD -0.02 -0.03
Stochastic Oscillator 73.91 37.22

Price Performance

Historical Comparison
GKOS
ORN

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About ORN Orion Group Holdings Inc.

Orion Group Holdings Inc is a specialty construction company serving the infrastructure, industrial, and building sectors, providing services both on and off the water in the continental United States, Alaska, Canada and the Caribbean Basin through its marine segment and its concrete segment. Its marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. Its concrete segment provides turnkey concrete construction services including pour and finish, dirt work, layout, forming, rebar and mesh across the light commercial, structural and other associated business areas.

Share on Social Networks: